The FDA recently issued Warning Letters to two overseas medical device manufacturers, citing significant violations of the Quality System Regulation (QSR) . This action is not a mere administrative notification; it sends a powerful message that the FDA is actively stepping up scrutiny of overseas manufacturing operations and their capacity for effective quality system management. Both companies were found to have systemic failures in product testing and validation procedures,

Read this, and you will understand the Food and Drug Administration's (FDA) Initial Importer for medical device stakeholders.

Date: 11/17/2023 Supported by the expertise of Provision Consulting Group, a leading global dental implant enterprise swiftly secured...